Actualizaciones regulatorias22 sept 2026•1 min de lectura

FDA Approves ANDA076850 for Terconazole Vaginal Suppository

Por el equipo de PharmaCountry

FDA granted approval (ANDA076850) for Fougera Pharms' terconazole 80 mg vaginal suppository, now listed as discontinued.

The U.S. Food and Drug Administration has approved an Abbreviated New Drug Application (ANDA) numbered ANDA076850 for a terconazole vaginal suppository. The product, marketed by Fougera Pharms, is a 80 mg terconazole suppository intended for vaginal administration. The submission was an original (ORIG) filing and received approval on July 12, 2006. FDA records indicate the product’s marketing status is listed as discontinued.

Recopilado por el equipo de PharmaCountry · Fuente: FDA.gov

Temas:#ANDA #Terconazole #Vaginal Suppository #FDA #Regulatory Approval #discontinued